sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
×Ô¾õÐÔÌÇÄò²¡¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ×Ô¾õÐÔÌÇÄò²¡¶¯ÎïÄ£×Ó

ǰÑÔ

ÌÇÄò²¡(diabetes)ÊÇÒ»ÖÖÒòÌåÄÚÒȵºËؾø¶Ô»òÕßÏà¶Ôȱ·¦Ëùµ¼ÖµÄһϵÁÐÁÙ´²×ÛºÏÕ÷£¬ÓëÒÅ´«»ùÒòÓÐןÜÊÇÇ×½üµÄ¹ØÁª¡£ÓÕ·¢ÌÇÄò²¡ÒòËØºÜÖØ´ó£¬ÔÚ´ó×ÚÈËȺÖÐÑо¿ÆÊÎöÕâЩÒòËØÊ®·ÖÄÑÌ⣬Òò´Ë£¬Ñо¿Ä³Ð©¶¯ÎïÖÖϵÌÇÄò²¡±¬·¢µÄ°Ù·ÖÂʼ°ÇéÐÎÒòËØ£¨Ñ¬È¾¡¢¶¾ËØ¡¢Òûʳ¼°Ò©ÎïµÈ£©¶ÔÓÕ·¢¶¯ÎïÌÇÄò²¡¼°Ä³Ð©²¢·¢Ö¢µÄÓ°Ï죬¿ÉΪ·ÀÖÎÈËÀàÌÇÄò²¡ÌṩÖ÷ÒªÏßË÷¡£¶ø¿¹ÌÇÄò²¡ÐÂÒ©µÄÑо¿£¬Ò²ÐëÏÈÊÔÓÃÓÚÌÇÄò²¡¶¯ÎÒÔÆÀ¼ÛÒ©ÎïµÄÁÆÐ§¼°Çå¾²ÐÔ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

×Ô¾õÐÔÌÇÄò²¡¶¯ÎïÓÖ³Æ×Ô¾õÐÔ¸ßѪÌǶ¯ÎÊǶ¯Îï×ÔÈ»±¬·¢µÄÌÇÄò²¡£¬»òͨ¹ýÒÅ´«ÓýÖÖ×÷Óý±£´æÏÂÀ´µÄÌÇÄò²¡Ä£×Ó£¬ÆäÌåÏÖÓëÈËÀàÌÇÄò²¡ÁÙ´²Ö¢×´ºÜÊÇÏàËÆ£¬¿ÉÓÃÓÚÌÇÄò²¡²¡Òò¼°·¢²¡»úÖÆµÄÑо¿£¬Ò²¿ÉÓÃÓÚ¿¹ÌÇÄò²¡Ò©ÎïµÄÑо¿¼°É¸Ñ¡¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

1.NODСÊó ·Ç·ÊÅÖÌÇÄò²¡Ð¡Êó[nonobese diabetes(NOD)   mouse]ÊÇJCL-ICRƷϵСÊóÑÜÉúµÄCTS£¨°×ÄÚÕÏÒ׸ÐÑÇϵ£©ÌÇÄò²¡Ð¡Êó½ü½»¶øÀ´£¬Æä·¢²¡¶àͻȻ£¬ÌåÏÖÏÔ×ŶàÒû¡¢¶àÄò¡¢ÏûÊÝ£¬ÑªÌÇÏÔÖøÉý¸ß£¬²»±ØÒȵºËØÖÎÁÆ£¬¶¯Îï´æ»î²»ÁËÒ»¸öÔ£¬Í¨³£ËÀÓÚͪѪ֢¡£NODСÊóÊÇÓÉT-ϸ°û£¨°üÀ¨CD4ºÍCD8ϸ°û£©½éµ¼µÄ£¬ÆäÉú³¤ÊÜ¿ØÓÚһϵÁÐTϸ°ûµÄµ÷Àí¡£βϸ°ûËðÉ˼̷¢ÓÚ×ÔÉíÃâÒßÀú³Ì£¬ÒýÆðµÍÒȵºËØÑªÖ¢¡£NODСÊóµÄÌÇÄò²¡·¢²¡ÂÊÓëÐÔ±ðÓйØ£¬ ´ÆÊó·¢²¡ÂÊÏÔÖø¸ßÓÚÐÛÐÔÊóÇÒ·¢²¡Ôç¡£

2.BB´óÊó Ò²½ÐBBDP(biobreeding diabetes­prone rat)´óÊó£¬ÊÇ´ÓWistar´óÊóÖÐɸѡ³öÀ´µÄÒ»ÖÖ×Ô¾õÐÔÒÅ´«ÐÔCÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó¡£Æä·¢²¡ºÍ×ÔÉíÃâÒßÐÔÆÆËðÒÈÏÙβϸ°ûÒý·¢ÒÈÏÙÑ×¼°ÒȵºËØÈ±·¦ÓйØ¡£BB´óÊóÌÇÄò²¡±¬·¢ÊÇͻȻµÄ£¬Ô¼ÄªÔÚ60~120ÈÕÁäʱ·¢²¡£¬ÊýÌìºó£¬ÌÇÄò²¡¶¯Îï·ºÆðÑÏÖØµÄ¸ßѪÌÇ¡¢µÍÒȵºËغÍͪѪ֢¡£

3.LEW.1NR1/ztm-iddm´óÊó ÊÇLewis´óÊóMHCµ¥±¶ÐÍ×Ô¾õÍ»±äÖ꣬×Ô¾õÐÔ×ÔÉíÃâÒß1ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó¡£58Ìì×óÓÒ·¢²¡£¬·¢²¡ÂÊΪ20%, ÐÔ±ð²»Ó°Ïì·¢²¡ÂÊ¡£ÌصãÊǸßѪÌÇ¡¢ÌÇÄò¡¢ÍªÄòºÍ¶àÄò¡£Òȵº±»Ñ×ÐÔϸ°û(BÁܰÍϸ°û¡¢TÁܰÍϸ°û¾ÞÊÉϸ°û¡¢NKϸ°û)½þÈó¡£±¬·¢ÒÈÏÙÑ׵IJ¿Î»βϸ°ûѸËÙµòÍö¡£

¡¾Ä£×ÓÌØµã¡¿£º

NODСÊó¡¢BBÌÇÄò²¡´óÊó¼°LEW. 1NR1/ztm-iddm´óÊó¾ùΪÑо¿×Ô¾õÐÔ×ÔÉíÃâÒß1ÐÍÌÇÄò²¡ºÜºÃµÄÄ£×Ó¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

NODСÊóÓëÈËÀà1ÐÍÌÇÄò²¡ÓÐÐí¶àÅäºÏÌØÕ÷£º¼²²¡Éú³¤ÊÇÓÉÐí¶à¼²²¡Ò׸ÐÐÔ»ò¶Ô¿¹»ùÒò¿ØÖÆ£¬°üÀ¨´ó²¿·Ö×éÖ¯ÏàÈÝÐÔÖØ´óµÄ»ùÒòλµã£¬¿ÉÓÃÓÚ1ÐÍÌÇÄò²¡µÄÑо¿¡£BBÌÇÄò²¡ÊóÄÜÄ£ÄâÈËÀà1ÐÍÌÇÄò²¡µÄ×ÔÈ»·¢²¡¡¢²¡³ÌÉú³¤ºÍת¹é£¬ÇÒûÓÐÍâÀ´ÒòËØµÄ¼ÓÈëºÍ×ÌÈÅ£¬Ò²ÊÇÒ»ÖÖÊ®·ÖÀíÏëµÄ1ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó¡£

 

²Î¿¼ÎÄÏ×£º

1.Àî´ÏÈ»£¬ÓÎÑ©¸¦£¬½¯½¨¶«. ÌÇÄò²¡¶¯ÎïÄ£×Ó¼°Ñо¿Ï£Íû. Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾£¬2005,15 (1):59-63

2.ÕÅÓñÁ죬Ëﳤò«£®2ÐÍÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÊÊÓÃÌÇÄò²¡ÔÓÖ¾£¬2011,7(4):7-9

3.ÕÅ´«²Ö£¬ÁõÎÀÅô£¬¶Å½­£¬µÈ£®¸ÄÁ¼ËÄÑõà×ष¨ÖÆ×÷ÌÇÄò²¡¶¯ÎïÄ£×Ó£®ÊÊÓÃҽѧÔÓÖ¾£¬2007,23 (5):623-624

4.³Â½¼Àö£¬ÑîÓ¨£®ÌÇÄò²¡ÊóÄ£×ÓÑо¿ÐÂÏ£Íû£®À¥Ã÷ҽѧԺѧ±¨£¬2012,2:144-146

5.ÕžùÌÏÖ´úÒ©ÀíʵÑéÒªÁì±±¾©£º±±¾©Ò½¿Æ´óѧÖйúЭºÍÒ½¿Æ´óѧÍŽá³öÊéÉ磬1998

6.ÐìÊåÔÆ£¬±åÈç奣¬³ÂÐÞÒ©ÀíʵÑéÒªÁìѧ£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2005

7.¸ßºìÀò£¬Áõ·½ÓÀ£¬ÏÄ×÷Àí. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÀíÂÛÑо¿ÓëÓ¦Óã®ÖйúÁÙ´²¿µ¸´£¬2005,9 (3):210-212

8.Åí·¼£¬ÑîÔ¶»ª. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓÖÆ±¸¼°Ö¸±ê²â¶¨ÆÀ¼Û. ´óÀíѧԺѧ±¨£¬2003, 2(1): 1-3

9.Aubert R, Herzog J, Camus MC, et al. Description of a new model of genetic obesity: the dbPas mouse. J Nutr, 1985, 115 (3):327-333

10.Hagenieldt-Johansson KA,Herrera PL,Wang H,et al. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor- I alpha induces a maturity­onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology, 2001, 142 (12):5311- 5320

11.Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL- 6J strains. Biochem Genet, 1972, 7 (1):1-13

12.Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest, 2000, 106(4):459-465

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ×Ô¾õÐÔÌÇÄò²¡¶¯ÎïÄ£×Ó
×Ô¾õÐÔÌÇÄò²¡¶¯ÎïÄ£×Ó

ǰÑÔ

ÌÇÄò²¡(diabetes)ÊÇÒ»ÖÖÒòÌåÄÚÒȵºËؾø¶Ô»òÕßÏà¶Ôȱ·¦Ëùµ¼ÖµÄһϵÁÐÁÙ´²×ÛºÏÕ÷£¬ÓëÒÅ´«»ùÒòÓÐןÜÊÇÇ×½üµÄ¹ØÁª¡£ÓÕ·¢ÌÇÄò²¡ÒòËØºÜÖØ´ó£¬ÔÚ´ó×ÚÈËȺÖÐÑо¿ÆÊÎöÕâЩÒòËØÊ®·ÖÄÑÌ⣬Òò´Ë£¬Ñо¿Ä³Ð©¶¯ÎïÖÖϵÌÇÄò²¡±¬·¢µÄ°Ù·ÖÂʼ°ÇéÐÎÒòËØ£¨Ñ¬È¾¡¢¶¾ËØ¡¢Òûʳ¼°Ò©ÎïµÈ£©¶ÔÓÕ·¢¶¯ÎïÌÇÄò²¡¼°Ä³Ð©²¢·¢Ö¢µÄÓ°Ï죬¿ÉΪ·ÀÖÎÈËÀàÌÇÄò²¡ÌṩÖ÷ÒªÏßË÷¡£¶ø¿¹ÌÇÄò²¡ÐÂÒ©µÄÑо¿£¬Ò²ÐëÏÈÊÔÓÃÓÚÌÇÄò²¡¶¯ÎÒÔÆÀ¼ÛÒ©ÎïµÄÁÆÐ§¼°Çå¾²ÐÔ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

×Ô¾õÐÔÌÇÄò²¡¶¯ÎïÓÖ³Æ×Ô¾õÐÔ¸ßѪÌǶ¯ÎÊǶ¯Îï×ÔÈ»±¬·¢µÄÌÇÄò²¡£¬»òͨ¹ýÒÅ´«ÓýÖÖ×÷Óý±£´æÏÂÀ´µÄÌÇÄò²¡Ä£×Ó£¬ÆäÌåÏÖÓëÈËÀàÌÇÄò²¡ÁÙ´²Ö¢×´ºÜÊÇÏàËÆ£¬¿ÉÓÃÓÚÌÇÄò²¡²¡Òò¼°·¢²¡»úÖÆµÄÑо¿£¬Ò²¿ÉÓÃÓÚ¿¹ÌÇÄò²¡Ò©ÎïµÄÑо¿¼°É¸Ñ¡¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

1.NODСÊó ·Ç·ÊÅÖÌÇÄò²¡Ð¡Êó[nonobese diabetes(NOD)   mouse]ÊÇJCL-ICRƷϵСÊóÑÜÉúµÄCTS£¨°×ÄÚÕÏÒ׸ÐÑÇϵ£©ÌÇÄò²¡Ð¡Êó½ü½»¶øÀ´£¬Æä·¢²¡¶àͻȻ£¬ÌåÏÖÏÔ×ŶàÒû¡¢¶àÄò¡¢ÏûÊÝ£¬ÑªÌÇÏÔÖøÉý¸ß£¬²»±ØÒȵºËØÖÎÁÆ£¬¶¯Îï´æ»î²»ÁËÒ»¸öÔ£¬Í¨³£ËÀÓÚͪѪ֢¡£NODСÊóÊÇÓÉT-ϸ°û£¨°üÀ¨CD4ºÍCD8ϸ°û£©½éµ¼µÄ£¬ÆäÉú³¤ÊÜ¿ØÓÚһϵÁÐTϸ°ûµÄµ÷Àí¡£βϸ°ûËðÉ˼̷¢ÓÚ×ÔÉíÃâÒßÀú³Ì£¬ÒýÆðµÍÒȵºËØÑªÖ¢¡£NODСÊóµÄÌÇÄò²¡·¢²¡ÂÊÓëÐÔ±ðÓйØ£¬ ´ÆÊó·¢²¡ÂÊÏÔÖø¸ßÓÚÐÛÐÔÊóÇÒ·¢²¡Ôç¡£

2.BB´óÊó Ò²½ÐBBDP(biobreeding diabetes­prone rat)´óÊó£¬ÊÇ´ÓWistar´óÊóÖÐɸѡ³öÀ´µÄÒ»ÖÖ×Ô¾õÐÔÒÅ´«ÐÔCÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó¡£Æä·¢²¡ºÍ×ÔÉíÃâÒßÐÔÆÆËðÒÈÏÙβϸ°ûÒý·¢ÒÈÏÙÑ×¼°ÒȵºËØÈ±·¦ÓйØ¡£BB´óÊóÌÇÄò²¡±¬·¢ÊÇͻȻµÄ£¬Ô¼ÄªÔÚ60~120ÈÕÁäʱ·¢²¡£¬ÊýÌìºó£¬ÌÇÄò²¡¶¯Îï·ºÆðÑÏÖØµÄ¸ßѪÌÇ¡¢µÍÒȵºËغÍͪѪ֢¡£

3.LEW.1NR1/ztm-iddm´óÊó ÊÇLewis´óÊóMHCµ¥±¶ÐÍ×Ô¾õÍ»±äÖ꣬×Ô¾õÐÔ×ÔÉíÃâÒß1ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó¡£58Ìì×óÓÒ·¢²¡£¬·¢²¡ÂÊΪ20%, ÐÔ±ð²»Ó°Ïì·¢²¡ÂÊ¡£ÌصãÊǸßѪÌÇ¡¢ÌÇÄò¡¢ÍªÄòºÍ¶àÄò¡£Òȵº±»Ñ×ÐÔϸ°û(BÁܰÍϸ°û¡¢TÁܰÍϸ°û¾ÞÊÉϸ°û¡¢NKϸ°û)½þÈó¡£±¬·¢ÒÈÏÙÑ׵IJ¿Î»βϸ°ûѸËÙµòÍö¡£

¡¾Ä£×ÓÌØµã¡¿£º

NODСÊó¡¢BBÌÇÄò²¡´óÊó¼°LEW. 1NR1/ztm-iddm´óÊó¾ùΪÑо¿×Ô¾õÐÔ×ÔÉíÃâÒß1ÐÍÌÇÄò²¡ºÜºÃµÄÄ£×Ó¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

NODСÊóÓëÈËÀà1ÐÍÌÇÄò²¡ÓÐÐí¶àÅäºÏÌØÕ÷£º¼²²¡Éú³¤ÊÇÓÉÐí¶à¼²²¡Ò׸ÐÐÔ»ò¶Ô¿¹»ùÒò¿ØÖÆ£¬°üÀ¨´ó²¿·Ö×éÖ¯ÏàÈÝÐÔÖØ´óµÄ»ùÒòλµã£¬¿ÉÓÃÓÚ1ÐÍÌÇÄò²¡µÄÑо¿¡£BBÌÇÄò²¡ÊóÄÜÄ£ÄâÈËÀà1ÐÍÌÇÄò²¡µÄ×ÔÈ»·¢²¡¡¢²¡³ÌÉú³¤ºÍת¹é£¬ÇÒûÓÐÍâÀ´ÒòËØµÄ¼ÓÈëºÍ×ÌÈÅ£¬Ò²ÊÇÒ»ÖÖÊ®·ÖÀíÏëµÄ1ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó¡£

 

²Î¿¼ÎÄÏ×£º

1.Àî´ÏÈ»£¬ÓÎÑ©¸¦£¬½¯½¨¶«. ÌÇÄò²¡¶¯ÎïÄ£×Ó¼°Ñо¿Ï£Íû. Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾£¬2005,15 (1):59-63

2.ÕÅÓñÁ죬Ëﳤò«£®2ÐÍÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÊÊÓÃÌÇÄò²¡ÔÓÖ¾£¬2011,7(4):7-9

3.ÕÅ´«²Ö£¬ÁõÎÀÅô£¬¶Å½­£¬µÈ£®¸ÄÁ¼ËÄÑõà×ष¨ÖÆ×÷ÌÇÄò²¡¶¯ÎïÄ£×Ó£®ÊÊÓÃҽѧÔÓÖ¾£¬2007,23 (5):623-624

4.³Â½¼Àö£¬ÑîÓ¨£®ÌÇÄò²¡ÊóÄ£×ÓÑо¿ÐÂÏ£Íû£®À¥Ã÷ҽѧԺѧ±¨£¬2012,2:144-146

5.ÕžùÌÏÖ´úÒ©ÀíʵÑéÒªÁì±±¾©£º±±¾©Ò½¿Æ´óѧÖйúЭºÍÒ½¿Æ´óѧÍŽá³öÊéÉ磬1998

6.ÐìÊåÔÆ£¬±åÈç奣¬³ÂÐÞÒ©ÀíʵÑéÒªÁìѧ£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2005

7.¸ßºìÀò£¬Áõ·½ÓÀ£¬ÏÄ×÷Àí. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÀíÂÛÑо¿ÓëÓ¦Óã®ÖйúÁÙ´²¿µ¸´£¬2005,9 (3):210-212

8.Åí·¼£¬ÑîÔ¶»ª. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓÖÆ±¸¼°Ö¸±ê²â¶¨ÆÀ¼Û. ´óÀíѧԺѧ±¨£¬2003, 2(1): 1-3

9.Aubert R, Herzog J, Camus MC, et al. Description of a new model of genetic obesity: the dbPas mouse. J Nutr, 1985, 115 (3):327-333

10.Hagenieldt-Johansson KA,Herrera PL,Wang H,et al. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor- I alpha induces a maturity­onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology, 2001, 142 (12):5311- 5320

11.Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL- 6J strains. Biochem Genet, 1972, 7 (1):1-13

12.Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest, 2000, 106(4):459-465

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿